Fig. 1From: Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 studyFlowchart of Phase 2 study of gemcitabine and docetaxel combination chemotherapy for sarcomasBack to article page